Phase II randomized study comparing FOLFIRINOX + Panitumumab versus mFOLFOX6 + Panitumumab in metastatic colorectal cancer patients selected by RAS and B-RAF status from circulating DNA analysis.
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
At a glance
- Drugs Panitumumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms UCGI28_PANIRINOX
- 24 Jan 2017 Status changed from not yet recruiting to recruiting.
- 25 Nov 2016 New trial record